Vimta Labs reverses recent rally

Vimta Labs lost 1.03% to Rs 139.90 at 15:10 IST on BSE, on profit booking after gaining 19.79% in the preceding eight trading sessions to settle at Rs 141.35 yesterday, 27 June 2017, from its close of Rs 118 on 14 June 2017.

Meanwhile, the S&P BSE Sensex was down 125.79 points, or 0.41% at 30,832.46. The S&P BSE Small-Cap index was up 18.40 points, or 0.12% at 15,159.48.

On the BSE, 29,000 shares were traded on the counter so far as against the average daily volumes of 46,598 shares in the past one quarter. The stock had hit a high of Rs 142 and a low of Rs 137.20 so far during the day. The stock had hit a 52-week high of Rs 153.90 on 27 June 2017. The stock had hit a 52-week low of Rs 68.75 on 28 June 2016.

The stock had outperformed the market over the past one month till 27 June 2017, rising 18.83% compared with 0.23% fall in the Sensex. The scrip had also outperformed the market in past one quarter, gaining 30.1% as against Sensex's 5.89% rise. The scrip had also outperformed the market in past one year, surging 102.22% as against Sensex's 17.25% rise.

The small-cap company has equity capital of Rs 4.42 crore. Face value per share is Rs 2.

Vimta Labs' net profit rose 32.6% to Rs 2.40 crore on 19.9% increase in net sales to Rs 39.47 crore in Q4 March 2017 over Q4 March 2016.

Vimta Labs is engaged in the business of contract research and testing services. The company provides services of testing and contract research in the fields of clinical and pre-clinical studies, clinical reference, analytical testing, advanced molecular biology and environmental studies.

Powered by Capital Market - Live News